H. Lundbeck A/S will pay a premium of approximately $658 million to acquire Chelsea Therapeutics International Ltd. (Nasdaq: CHTP). Shares of the biopharmaceutical soared $1.55 to $6.55.
Chelsea Therapeutics To Be Acquired
May 08, 2014 at 13:27 PM EDT